Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
McKesson
Healthtrust
Argus Health
Novartis
Cipla
Teva
AstraZeneca
Federal Trade Commission

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,559,269

« Back to Dashboard

Summary for Patent: 5,559,269
Title: 3,3-diphenylpropylamines, their use and preparation
Abstract:The invention relates to 3,3-diphenylpropylamines of formula (I), wherein R.sup.1 signifies hydrogen or methyl, R.sup.2 and R.sup.3 independently signify hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphamoyl or halogen, and X represents a tertiary amino group of formula (II), wherein R.sup.4 and R.sup.5 signify non-aromatic hydrocarbyl groups, which may be the same or different and which together contain at least three carbon atoms, and wherein R.sup.4 and R.sup.5 may form a ring together with the amine nitrogen, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers. The invention also relates to methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for preparing drugs ##STR1##
Inventor(s): Johansson; Rolf A. (Huddinge, SE), Moses; Pinchas (Satsj o-Boo, SE), Nilvebrant; Lisbeth (Bromma, SE), Sparf; Bengt .ANG.. (Tr.ang.ngsund, SE)
Assignee: Pharmacia AB (Stockholm, SE)
Application Number:08/432,113
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use;

Drugs Protected by US Patent 5,559,269

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,559,269

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9203318Nov 06, 1992

International Patents Family Members for US Patent 5,559,269

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 164828 ➤ Subscribe
Australia 5438094 ➤ Subscribe
Australia 672458 ➤ Subscribe
Canada 2148827 ➤ Subscribe
Germany 69317898 ➤ Subscribe
Denmark 0667852 ➤ Subscribe
European Patent Office 0667852 ➤ Subscribe
Spain 2117155 ➤ Subscribe
Finland 120256 ➤ Subscribe
Finland 952179 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Chinese Patent Office
US Department of Justice
Citi
Novartis
Fish and Richardson
Deloitte
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot